The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017
Andrew Selby
2134/27699
https://repository.lboro.ac.uk/articles/figure/The_Lancet_Gastroenterology_Hepatology_Journal_Cover_January_2nd_2017/9334436
The strongest risk factor for oesophageal adenocarcinoma (OAC) is reflux disease, and the rising incidence coincides with the eradication of Helicobacter pylori, both of which may alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett’s carcinogenesis and investigate the Cytosponge™ as a minimally invasive tool for sampling the oesophageal microbiota.
2017-12-07 14:14:25
Cytosponge
Lancet
Gastroenterology
Hepatology
Studies in the Creative Arts and Writing not elsewhere classified